IMMIX BIOPHARMA, INC. IMMX 深 滬
等待開盤 09-20 09:30:00 美东时间
1.77
-0.010
-0.56%
華盛通- 最 高1.8692
- 今 開1.83
- 成交量 7.51万股
- 最 低 1.755
- 昨 收 1.78
- 總市值 4496.21万
- 52周最高 7.75
- 市盈率 靜 --
- 換手率 0.30%
- 52周最低 1.7503
- 委 比 40.65%
- 總股本 2540.23万
- 歷史最高 8.68
- 量 比 1.34
- 振 幅 6.42%
- 歷史最低 0.68
- 每 手 1
- 風險率 1.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Immix Biopharma Shareholders Back Growth and Governance Changes
Immix Biopharma, Inc. (IMMX) has shared an announcement. At Immix Biopharma, In...
06-15 06:00
Immix Biopharma On Track To Dose NXC-201 U.S. Patients
Scheduling U.S. site initiation visits April and May 2024On track to dose relapsed/refractory AL Amyloidosis patients with CAR-T NXC-201 at New York City lead site and other leading U.S. sites mid-2024No change in
04-18 21:46
Immix Biopharma Announces 12-Month Progress Update Including Shareholder Letter
Immix Biopharma, Inc. (NASDAQ:IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced its 12-month progress update including shareholder letter. "The
02-21 22:39
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) stock rose 57.8% to $0.38 during ...
2023-12-16 01:31
美股牛股 | 美股新股INHD上市首日飙升246%！高途周内累涨72%
美股新股INHD上市首日飙升246%；东方甄选“小作文”事件持续发酵，高途“坐收渔利”，隔夜暴涨29%，周内累涨72%。详情>>
2023-12-15 19:59
Immix Biopharma Announces Complete Response In 9th Relapsed/Refractory AL Amyloidosis Patient In NXC-201 Clinical Trial At IMS 20th Annual Meeting
100% (9/9) overall response rate and 67% (6/9) complete response rate (MRD 10-5) observed in heavily pre-treated patients with daratumumab relapsed/refractory AL Amyloidosis as of the September 20, 2023 data cutoff100%
2023-10-03 21:16
Roth MKM Reiterates Buy on Immix Biopharma, Maintains $14 Price Target
Roth MKM analyst Jonathan Aschoff reiterates Immix Biopharma (NASDAQ:IMMX) with a Buy and maintains $14 price target.
2023-08-14 22:11
Immix Biopharma Analyst Ratings
What is the target price for Immix Biopharma (IMMX)?The latest price target for...
2023-08-14 22:10
5 Biotech Stocks Under $5: Bionano Genomics, Northwest BioTherapeutics Plus 3 More Stocks
September 15, 2022 – The biotechnology industry is a vast sector consisting of ...
2023-07-24 19:08
Immatics Biotechnologies Granted U.S. Patent #11685769: Peptides for use in immunotherapy against cancers
https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11685769
2023-06-27 17:39
